Raymond John Owens

Title: The Innovations of Raymond John Owens

Introduction

Raymond John Owens is a notable inventor based in Henley-on-Thames, GB. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 10 patents to his name, Owens has established himself as a key figure in the advancement of therapeutic antibodies.

Latest Patents

Owens' latest patents include groundbreaking work on Anti-HMFG antibodies and processes for their production. These humanized antibody molecules (HAMs) exhibit specificity for human milk fat globule and feature an antigen binding site derived from the mouse monoclonal antibody CTMO1. The remaining components of the HAM are derived from human immunoglobulin, making them suitable for in vivo diagnosis and therapy. Another significant patent involves antibodies against E-selectin, which are whole antibodies of neutral isotype designed for therapeutic use in inflammatory disorders. These antibodies are engineered to minimize interactions with antibody F receptors and complement, enhancing their therapeutic potential.

Career Highlights

Throughout his career, Owens has worked with prominent companies in the biotechnology sector, including Celltech Therapeutics Limited and Celltech Limited. His work has focused on the development of innovative therapeutic solutions that address various medical conditions.

Collaborations

Owens has collaborated with esteemed colleagues in the field, including John Robert Adair and Mark William Bodmer. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Raymond John Owens is a distinguished inventor whose work in the field of humanized antibodies has paved the way for new therapeutic approaches. His contributions continue to impact the biotechnology industry positively.